E-DRUG: Re: Nimiodipine

Larry,

Nimodipine is on the market in Canada as an "adjunct in the management of
subarachnoid hemorrhage". I was at an expert advisory committee meeting
in Ottawa yesterday that discussed the controversies over CCBs as a whole
during which nimodipine came up. The details cannot be released, of
course, but as you are likely aware, there is recent concern re: CCBs and
adverse effects including bleeding, the latter having been looked at in
CABG with nimodipine.

Hope this helps. I would be interested in knowing what other countries are doing with all of their calcium channel blocking agents
including nimodipine in light of the controversies.

regards, anne holbrook